Skip to main content
. 2019 Apr 1;10:652. doi: 10.3389/fimmu.2019.00652

Figure 5.

Figure 5

Depleting CD25+ Tregs reverses skin allograft survival prolonged by shikonin. C57BL/6 mice were transplanted with BALB/C skin and treated with shikonin (40 mg/kg) or CsA (20 mg/kg) for 14 consecutive days or until allograft rejection. They were also depleted of CD4+CD25+ Tregs through injection of anti-CD25 Ab (PC61), as described in the methods. Skin allograft survival times were observed (*P < 0.05 and **P < 0.01, n = 8–9 mice).